Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTangible Book ValueTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Current Deferred Revenue (2022 - 2024)

Historic Current Deferred Revenue for NewGenIvf (NIVF) over the last 3 years, with Q4 2024 value amounting to $63489.0.

  • NewGenIvf's Current Deferred Revenue rose 69991.18% to $63489.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $63489.0, marking a year-over-year increase of 69991.18%. This contributed to the annual value of $63489.0 for FY2024, which is 69991.18% up from last year.
  • NewGenIvf's Current Deferred Revenue amounted to $63489.0 in Q4 2024, which was up 69991.18% from $7937.0 recorded in Q4 2023.
  • Over the past 5 years, NewGenIvf's Current Deferred Revenue peaked at $1.4 million during Q4 2022, and registered a low of $7937.0 during Q4 2023.
  • In the last 3 years, NewGenIvf's Current Deferred Revenue had a median value of $63489.0 in 2024 and averaged $477198.0.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first tumbled by 9941.65% in 2023, then soared by 69991.18% in 2024.
  • Over the past 3 years, NewGenIvf's Current Deferred Revenue (Quarter) stood at $1.4 million in 2022, then plummeted by 99.42% to $7937.0 in 2023, then skyrocketed by 699.91% to $63489.0 in 2024.
  • Its Current Deferred Revenue was $63489.0 in Q4 2024, compared to $7937.0 in Q4 2023 and $1.4 million in Q4 2022.